Status:
COMPLETED
Optimal Endotracheal Cuff Pressure During Hospitalization in Intensive Care Units Using AnapnoGuard 100 System
Lead Sponsor:
Hospitech Respiration
Conditions:
Ventilator Associated Pneumonia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hospitech Respiration Ltd has developed the AnapnoGuard system, an innovative system intended to enhance optimal endotracheal tube (ETT) cuff inflation, by monitoring carbon dioxide (CO2) in upper air...
Eligibility Criteria
Inclusion
- Age above 18 (men and woman);
- Patient is admitted to ICU and expected to receive mechanical ventilation for at least 48 hours;
- Normal chest X-ray;
- Connection of the ETT to the AnapnoGuard system less than 6 hours from intubation initiation;
- Signed informed consent by subject's legally acceptable representative.
Exclusion
- Patients who had been treated with mechanical ventilation during the last year;
- Fever from known chest/lung origin;
- Patients with facial, oropharyngeal or neck trauma;
- BMI\>35;
- Height \< 1.6 m;
- Any chest X-ray pathology during the first 24 hours post intubation;
- More than 7 days hospitalization prior to the intubation. Chest/lung infection.
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01188122
Start Date
April 1 2008
End Date
September 1 2009
Last Update
August 25 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Spitalu Universitar De Urgente Elias Hospital
Bucharest, Romania